Specialized PPI formulations — the range of modified-release, dispersible, nasogastric tube-compatible, and combination formulations serving patients with specific administration challenges or clinical needs — represent the pharmaceutical innovation that maintains differentiation in an otherwise commoditized PPI market, with the Proton Pump Inhibitors Market reflecting formulation...